Commentary on "Solving the benign prostatic hyperplasia puzzle".
作者信息
Thomas Dominique, Chughtai Bilal, Kaplan Steven
机构信息
Department of Urology, Weill Cornell Medicine/New-York Presbyterian Hospital, New York, NY, USA.
Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
出版信息
Asian J Urol. 2018 Jan;5(1):10-11. doi: 10.1016/j.ajur.2016.09.007. Epub 2016 Sep 20.
Abstract
摘要
相似文献
1
Commentary on "Solving the benign prostatic hyperplasia puzzle".
Asian J Urol. 2018 Jan;5(1):10-11. doi: 10.1016/j.ajur.2016.09.007. Epub 2016 Sep 20.
2
Solving the benign prostatic hyperplasia puzzle.
Asian J Urol. 2016 Jan;3(1):6-9. doi: 10.1016/j.ajur.2015.11.003. Epub 2015 Nov 26.
3
[Incidence of benign prostatic hyperplasia and hepatic cirrhosis].
Praxis (Bern 1994). 1999 Sep 9;88(37):1467-74.
4
Recent advances in prostatectomy for benign prostatic hyperplasia.
F1000Res. 2019 Aug 29;8. doi: 10.12688/f1000research.18179.1. eCollection 2019.
5
Estrogen receptor in human benign prostatic hyperplasia.
J Urol. 1983 Jul;130(1):183-7. doi: 10.1016/s0022-5347(17)51020-4.
6
The overlapping lower urinary tract symptoms of benign prostatic hyperplasia and prostatitis.
Curr Opin Urol. 2006 Jan;16(1):5-10. doi: 10.1097/01.mou.0000193365.46081.cd.
7
Health-related quality of life and psychological well-being in men with benign prostatic hyperplasia: An integrative review.
Jpn J Nurs Sci. 2016 Jul;13(3):309-23. doi: 10.1111/jjns.12115. Epub 2016 Jan 19.
8
Alcohol consumption is associated with a decreased risk of benign prostatic hyperplasia.
J Urol. 2009 Oct;182(4):1463-8. doi: 10.1016/j.juro.2009.06.038. Epub 2009 Aug 15.
9
Diabetes and benign prostatic hyperplasia/lower urinary tract symptoms--what do we know?
J Urol. 2009 Dec;182(6 Suppl):S32-7. doi: 10.1016/j.juro.2009.07.088.
10
Effects of silodosin and tamsulosin on the urethra and cardiovascular system in young and old dogs with benign prostatic hyperplasia.
Eur J Pharmacol. 2009 Jun 24;613(1-3):135-40. doi: 10.1016/j.ejphar.2009.04.030. Epub 2009 Apr 21.
引用本文的文献
1
Current consensus and controversies on male LUTS/BPH (part two).
Asian J Urol. 2018 Jan;5(1):8-9. doi: 10.1016/j.ajur.2017.11.007. Epub 2017 Dec 6.
本文引用的文献
1
Solving the benign prostatic hyperplasia puzzle.
Asian J Urol. 2016 Jan;3(1):6-9. doi: 10.1016/j.ajur.2015.11.003. Epub 2015 Nov 26.
2
Benign prostatic hyperplasia.
Nat Rev Dis Primers. 2016 May 5;2:16031. doi: 10.1038/nrdp.2016.31.
3
Intravesical Prostatic Protrusion as a Predicting Factor for the Adverse Clinical Outcome in Patients With Symptomatic Benign Prostatic Enlargement Treated With Dutasteride.
Urology. 2016 May;91:154-7. doi: 10.1016/j.urology.2016.01.009. Epub 2016 Jan 27.
4
Terminal dribbling in male patients with lower urinary tract symptoms: relationship with International Prostate Symptom Score and with intravesical prostatic protrusion.
BMC Urol. 2015 Aug 29;15:89. doi: 10.1186/s12894-015-0082-x.
5
Diagnosis of prostate adenoma and the relationship between the site of prostate adenoma and bladder outlet obstruction.
Singapore Med J. 2013 Sep;54(9):482-6. doi: 10.11622/smedj.2013168.
6
Intravesical prostatic protrusion predicts clinical progression of benign prostatic enlargement in patients receiving medical treatment.
Int J Urol. 2010 Jan;17(1):69-74. doi: 10.1111/j.1442-2042.2009.02409.x. Epub 2009 Nov 16.
7
High risk prostate cancer: evolving definition and approach to management.
Can J Urol. 2008 Dec;15(6):4375-80.
8
Pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia.
Rev Urol. 2004;6 Suppl 9(Suppl 9):S3-S10.
9
Correlation of intravesical prostatic protrusion with bladder outlet obstruction.
BJU Int. 2003 Mar;91(4):371-4. doi: 10.1046/j.1464-410x.2003.04088.x.
10
Comparison of parameters to determine the cause of urinary disturbance in men with prostate volume less than 20 milliliters.
Int J Urol. 2002 Oct;9(10):554-9; discussion 560. doi: 10.1046/j.1442-2042.2002.00524.x.
Zotero 插件